Home › Critical Illness › NCT07222007

Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients

Association of Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients: A Large-Scale Retrospective Cohort Analysis

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Age ≥ 18 years
* Admission to the surgical ICU for critical care
* Administration of one of the studied induction agents
* Availability of complete clinical data

Exclusion Criteria:

* Age \< 18 years
* Absence of documented induction agent administration
* Incomplete or missing medical records

About the study

The aim of this retrospective cohort study is to compare the safety and efficacy of induction agents for tracheal intubation in critically ill adult patients.

What is being tested

• induction type for intubation in ICU (procedure)

Sponsor: Zeliha Alicikus · Participants: 4 · Started: Apr 18, 2026

Contact the study team

• TOLGA SARAÇOĞLU, Prof,MD · Phone: +1 (904) 524-5932
• Tolga Saraçoğlu, Asc Prof,MD · Phone: +1 (904) 524-5932

Official record on ClinicalTrials.gov — NCT07222007

Locations in the U.S.

Conditions

• Critical Illness

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.